It would also be interesting to examine the possible role of PARP1-dependent chromatin alterations in muscle pathologies, such rhabdomyosarcoma, in which the failure to activate some myogenic targets correlates with the defective MyoD binding to their regulatory regions24. This evidence concerns the gene MYOD1 and rhabdomyosarcoma.